PROCTER & GAMBLE HEALTH
|
PROCTER & GAMBLE HEALTH Last 5 Year Financial Ratios History
[Standalone]
| Jun2023 | Jun2022 | Jun2021 | Jun2020 | Dec2018 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 138.23 | 115.98 | 106.51 | 153.06 | 61.29 |
| CEPS(Rs) | 155.16 | 132.29 | 124.60 | 170.80 | 74.01 |
| DPS(Rs) | 95.00 | 52.50 | 130.00 | 230.00 | 440.00 |
| Book NAV/Share(Rs) | 447.62 | 366.99 | 421.59 | 544.82 | 927.78 |
| Tax Rate(%) | 26.97 | 24.02 | 24.21 | 28.40 | 35.60 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.44 | 22.73 | 24.39 | 23.18 | 16.98 |
| EBIT Margin(%) | 23.71 | 21.55 | 23.21 | 26.17 | 18.61 |
| Pre Tax Margin(%) | 23.66 | 21.51 | 23.13 | 26.17 | 18.61 |
| PAT Margin (%) | 17.28 | 16.35 | 17.53 | 18.74 | 11.98 |
| Cash Profit Margin (%) | 19.39 | 18.64 | 20.50 | 20.91 | 14.47 |
| Performance Ratios | |||||
| ROA(%) | 11.00 | 9.83 | 8.65 | 10.82 | 4.96 |
| ROE(%) | 33.94 | 29.41 | 22.04 | 20.79 | 8.95 |
| ROCE(%) | 46.07 | 38.45 | 29.08 | 29.01 | 13.90 |
| Asset Turnover(x) | 0.64 | 0.60 | 0.49 | 0.58 | 0.41 |
| Sales/Fixed Asset(x) | 5.27 | 5.17 | 4.87 | 7.04 | 4.50 |
| Working Capital/Sales(x) | 2.70 | 3.13 | 2.07 | 1.87 | 0.63 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.19 | 0.19 | 0.21 | 0.14 | 0.22 |
| Receivable days | 27.36 | 22.20 | 28.06 | 21.73 | 40.59 |
| Inventory Days | 34.37 | 36.19 | 45.68 | 33.31 | 58.27 |
| Payable days | 206.35 | 188.51 | 177.09 | 90.99 | 116.16 |
| Valuation Parameters | |||||
| PER(x) | 37.97 | 36.10 | 52.52 | 26.57 | 50.32 |
| PCE(x) | 33.83 | 31.65 | 44.89 | 23.81 | 41.67 |
| Price/Book(x) | 11.73 | 11.41 | 13.27 | 7.47 | 3.32 |
| Yield(%) | 1.81 | 1.25 | 2.32 | 5.65 | 14.27 |
| EV/Net Sales(x) | 6.73 | 5.95 | 8.74 | 4.51 | 4.57 |
| EV/Core EBITDA(x) | 24.12 | 23.59 | 33.38 | 15.91 | 22.47 |
| EV/EBIT(x) | 26.27 | 26.11 | 37.67 | 17.23 | 24.54 |
| EV/CE(x) | 3.71 | 3.42 | 4.46 | 2.89 | 1.50 |
| M Cap / Sales | 7.09 | 6.24 | 9.21 | 4.98 | 6.03 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 10.34 | 10.48 | -25.60 | 59.70 | 21.61 |
| Core EBITDA Growth(%) | 22.15 | 6.34 | -31.27 | 122.73 | 70.76 |
| EBIT Growth(%) | 24.11 | 8.42 | -34.03 | 124.62 | 59.70 |
| PAT Growth(%) | 19.19 | 8.89 | -30.42 | 149.73 | 66.68 |
| EPS Growth(%) | 19.19 | 8.89 | -30.42 | 149.73 | 66.68 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 1.72 | 1.62 | 1.89 | 2.35 | 3.45 |
| Quick Ratio(x) | 1.53 | 1.43 | 1.67 | 2.10 | 3.24 |
| Interest Cover(x) | 409.05 | 604.26 | 292.60 | - | - |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of PROCTER & GAMBLE HEALTH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PROCTER & GAMBLE HEALTH | ₹7,862.3 Cr | -1.7% | -6% | 1.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PROCTER & GAMBLE HEALTH | -1.7% |
-6% |
1.3% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
